Search

everythinglearnresearchcommunity

for

Search:↓

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

The document does not determine if adults with aphallia are fertile.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Skin health and diseases are closely linked to metabolic processes.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Finasteride and dutasteride can cause severe, lasting side effects.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Cimetidine did not reduce hair growth in women with hirsutism.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.